H D Royer

1.8k total citations
19 papers, 1.6k citations indexed

About

H D Royer is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, H D Royer has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in H D Royer's work include Monoclonal and Polyclonal Antibodies Research (6 papers), T-cell and B-cell Immunology (4 papers) and RNA and protein synthesis mechanisms (4 papers). H D Royer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), T-cell and B-cell Immunology (4 papers) and RNA and protein synthesis mechanisms (4 papers). H D Royer collaborates with scholars based in Germany, United States and Italy. H D Royer's co-authors include Karsten Jürchott, Ellis L. Reinherz, Oreste Acuto, Guido Gaietta, Michael Karin, Jens Andersen, Ching‐Yi Chen, Matthias Mann, Roberto Gherzi and Manfred Dietel and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

H D Royer

19 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H D Royer Germany 17 998 482 357 172 166 19 1.6k
H.‐G. Thiele Germany 23 545 0.5× 834 1.7× 451 1.3× 141 0.8× 226 1.4× 75 1.8k
M Shearer United Kingdom 20 782 0.8× 530 1.1× 660 1.8× 172 1.0× 222 1.3× 27 1.6k
C. Henne Germany 10 737 0.7× 551 1.1× 310 0.9× 124 0.7× 66 0.4× 15 1.2k
Cinda M. Boyer United States 18 620 0.6× 656 1.4× 537 1.5× 260 1.5× 93 0.6× 31 1.5k
A Ishii Japan 9 949 1.0× 866 1.8× 274 0.8× 163 0.9× 59 0.4× 19 1.6k
John A. Feild United States 16 905 0.9× 181 0.4× 405 1.1× 275 1.6× 341 2.1× 24 1.5k
Yiu‐Loon Chui Hong Kong 19 580 0.6× 399 0.8× 310 0.9× 217 1.3× 71 0.4× 45 1.2k
Marshall D. Sklar United States 14 615 0.6× 236 0.5× 398 1.1× 105 0.6× 206 1.2× 18 1.1k
Frederick W. Alt United States 14 1.1k 1.1× 1.4k 2.9× 461 1.3× 233 1.4× 146 0.9× 17 2.4k
Dale R. Taylor United Kingdom 9 522 0.5× 892 1.9× 285 0.8× 87 0.5× 114 0.7× 12 1.6k

Countries citing papers authored by H D Royer

Since Specialization
Citations

This map shows the geographic impact of H D Royer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H D Royer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H D Royer more than expected).

Fields of papers citing papers by H D Royer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H D Royer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H D Royer. The network helps show where H D Royer may publish in the future.

Co-authorship network of co-authors of H D Royer

This figure shows the co-authorship network connecting the top 25 collaborators of H D Royer. A scholar is included among the top collaborators of H D Royer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H D Royer. H D Royer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Eckstein, Niels, Kati Servan, Luc Girard, et al.. (2007). Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells. Journal of Biological Chemistry. 283(2). 739–750. 85 indexed citations
2.
Jürchott, Karsten, Stephan Bergmann, Ulrike Stein, et al.. (2003). YB-1 as a Cell Cycle-regulated Transcription Factor Facilitating Cyclin A and Cyclin B1 Gene Expression. Journal of Biological Chemistry. 278(30). 27988–27996. 186 indexed citations
3.
Grinstein, Edgar, et al.. (2002). Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells. Oncogene. 21(10). 1485–1492. 92 indexed citations
4.
Grinstein, Edgar, Peter Wernet, Peter J.F. Snijders, et al.. (2002). Nucleolin as Activator of Human Papillomavirus Type 18 Oncogene Transcription in Cervical Cancer. The Journal of Experimental Medicine. 196(8). 1067–1078. 58 indexed citations
5.
Chen, Ching‐Yi, Roberto Gherzi, Jens Andersen, et al.. (2000). Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes & Development. 14(10). 1236–1248. 327 indexed citations
6.
Bargou, Ralf C., Christian Wagener, Kurt Bommert, et al.. (1996). Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.. Journal of Clinical Investigation. 97(11). 2651–2659. 167 indexed citations
7.
Grinstein, Edgar & H D Royer. (1995). Multiple Octamer-Binding Proteins Are Targets for the Cell Cycle-Regulated Nuclear Inhibitor 1-92. DNA and Cell Biology. 14(6). 493–500. 3 indexed citations
8.
Hofmann, Walter, H D Royer, Matthias Drechsler, Susanne A. Schneider, & Brigitte Royer‐Pokora. (1993). Characterization of the transcriptional regulatory region of the human WT1 gene.. PubMed. 8(11). 3123–32. 45 indexed citations
9.
Royer‐Pokora, Brigitte, Hajo Delius, F. L. Kisseljov, et al.. (1992). Tissue restricted expression and chromosomal localization of the YB-1 gene encoding a 42kD nuclear CCAAT binding protein. Nucleic Acids Research. 20(4). 797–803. 49 indexed citations
10.
Bauknecht, Tobias, Peter Angel, H D Royer, & Harald zur Hausen. (1992). Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1.. The EMBO Journal. 11(12). 4607–4617. 124 indexed citations
12.
Royer, H D, et al.. (1989). DNA binding proteins present in guanidinium isothiocyanate lysates of cells are suitable for specific binding site blotting. Nucleic Acids Research. 17(21). 8891–8891. 2 indexed citations
13.
Royer, H D & Ellis L. Reinherz. (1987). T Lymphocytes: Ontogeny, Function, and Relevance to Clinical Disorders. New England Journal of Medicine. 317(18). 1136–1142. 68 indexed citations
14.
Schmidt, Reinhold E., J F Daley, H D Royer, et al.. (1986). Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity.. The Journal of Experimental Medicine. 163(4). 812–825. 24 indexed citations
16.
Royer, H D, Dunia Ramarli, Oreste Acuto, Thomas J. Campen, & E L Reinherz. (1985). Genes encoding the T-cell receptor alpha and beta subunits are transcribed in an ordered manner during intrathymic ontogeny.. Proceedings of the National Academy of Sciences. 82(16). 5510–5514. 86 indexed citations
17.
Royer, H D, Armand Bensussan, Oreste Acuto, & Ellis L. Reinherz. (1984). Functional isotypes are not encoded by the constant region genes of the beta subunit of the T cell receptor for antigen/major histocompatibility complex.. The Journal of Experimental Medicine. 160(3). 947–952. 45 indexed citations
18.
Acuto, Oreste, Marina Fabbi, J. E. Smart, et al.. (1984). Purification and NH2-terminal amino acid sequencing of the beta subunit of a human T-cell antigen receptor.. Proceedings of the National Academy of Sciences. 81(12). 3851–3855. 77 indexed citations
19.
Henning, U., H D Royer, R. M. Teather, I Hindennach, & C.P. Hollenberg. (1979). Cloning of the structural gene (ompA) for an integral outer membrane protein of Escherichia coli K-12.. Proceedings of the National Academy of Sciences. 76(9). 4360–4364. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026